SEC Form 4 · accession 0001209191-19-003317
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daphne Quimi
Officer — Chief Financial Officer
Period of report
Jan 2, 2019
Accepted (ET)
Jan 10, 2019 · 6:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1,F2 | Jan 2, 2019 | A | 57,471 | — | A | 121,803 | D | |
| Common stock | Jan 3, 2019 | F | 3,850 | $10.33 | D | 117,953 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F3 | $10.04 | Jan 2, 2019 | A | 88,154 | A | — | Jan 2, 2029 | Common stock | 88,154 | 88,154 | D |
Explanation of responses
- F1Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock.
- F2The Restricted Stock Units will vest in four equal annual installments beginning on January 2, 2020.
- F3These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on the first anniversary of the grant date. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments beginning on the first month thereafter.